CRIZOTINIB-INDUCED OSTEITIS MIMICKING BONE METASTASIS IN A STAGE IV ALK-REARRANGED NSCLC PATIENT: A CASE REPORT

Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report

Abstract Background Targeted therapies are a standard of care for first-line iphone 14 price arizona treatment of Anaplastic lymphoma kinase (ALK)-rearranged non small cell lung cancer (NSCLC).Giving the rapid pace of drug discovery and development in this area, reporting of adverse effects of ALK inhibitors is crucial.Here, we report a case of ost

read more